Imbio PHA (4.0.0) vs Sonix Health

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Imbio PHA (4.0.0)

by Imbio (a subsidiary of 4DMedical)

Sonix Health

by Ontact Health Co.

AI Verdict

Imbio PHA specializes in analyzing CT pulmonary angiogram (CTPA) scans for right ventricular dilation and pulmonary issues, while Sonix Health focuses on automating measurements and reporting from echocardiography images. While both are FDA-cleared AI tools for cardiology, their distinct imaging modalities and specific diagnostic applications make them complementary rather than directly competitive. A choice between them depends entirely on the type of cardiac imaging data requiring analysis.

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA (4.0.0) if your primary imaging modality for cardiac assessment is CT pulmonary angiogram (CTPA) scans. This tool is specifically designed to automatically measure cardiac structures from CTPA scans to assess potential right ventricular dilation, aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension.

View Imbio PHA (4.0.0) →

Choose Sonix Health if…

Choose Sonix Health if your practice heavily utilizes echocardiography and requires automated, comprehensive analysis of cardiac ultrasound images. This solution is ideal for enhancing efficiency and diagnostic precision in echocardiography, offering features like view recognition, automated quantification of B-mode, M-mode, Doppler parameters, and advanced strain analysis without EKG.

View Sonix Health →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Imbio PHA (4.0.0)	Sonix Health
Pricing	Unknown	Contact vendor for pricing.
Deployment	Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel).	Software only, installed directly on customer PC hardware; also offers cloud or on-premise options.
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Imbio PHA (4.0.0)	Sonix Health
Name	Imbio PHA (4.0.0)	Sonix Health
Company	Imbio	Ontact Health Co.
Primary Imaging Modality	CT pulmonary angiogram (CTPA) scans	Echocardiography (cardiac ultrasound images)
Key Cardiac Measurements/Analysis	Automated measurement of right and left ventricle diameters; automated measurement of main pulmonary artery and aorta diameters; calculates RV/LV and PA/Ao ratios.	View Recognition (classification of 37 FDA-approved views); Auto Measure (automated quantification of B-mode, M-mode, Doppler parameters); Auto Strain (automated LV, LA, and RV Strain analysis); Image Quality Meter.
Output Formats	Annotated DICOM images, summary reports in PDF format.	Automated Report Generation, DICOM Compliant.
Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Critical Care, Radiology

Videos

Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Sonix Health.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What imaging modalities do these AI tools support?

Imbio PHA (4.0.0) is designed to process CT pulmonary angiogram (CTPA) scans to measure cardiac structures. In contrast, Sonix Health analyzes echocardiography (cardiac ultrasound) images for automated measurement and reporting.

What specific cardiac measurements and analyses do each of these AI tools provide?

Imbio PHA (4.0.0) provides automated measurements of right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculates RV/LV and PA/Ao ratios. Sonix Health offers automated quantification of B-mode, M-mode, and Doppler parameters, along with automated LV, LA, and RV Strain analysis without EKG.

Which clinical specialties are best served by each tool?

Imbio PHA (4.0.0) is intended for use by Thoracic Radiologists, General Radiologists, Pulmonologists, and Cardiologists. Sonix Health serves Cardiology, Critical Care, and Radiology specialties.

Do both tools integrate with existing clinical workflows and systems?

Yes, both tools are designed for integration. Imbio PHA (4.0.0) integrates with native DICOM tools and workflows and generates annotated DICOM images and summary reports in DICOM compatible formats. Sonix Health is DICOM Compliant and offers multi-vendor, multi-device support.

What is the primary clinical application or focus of each AI solution?

Imbio PHA (4.0.0) is designed to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension from CTPA scans. Sonix Health aims to automate the measurement and reporting of cardiac ultrasound images to enhance efficiency and diagnostic precision for physicians.

Are both solutions vendor-independent for their respective imaging modalities?

Sonix Health explicitly states it utilizes vendor-independent technology and operates seamlessly across various systems. While Imbio PHA (4.0.0) integrates with native DICOM tools and workflows, its explicit vendor independence is not stated in the provided information.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform